Ispire Technology Inc. Common Stock logo

Ispire Technology Inc. Common Stock(ISPR)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 5 days
PROFIT SINCE LAST BUY
+1.2% ▲
LAST CLOSE
$1.69
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ISPR

11/13/2026: ISPR (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Ispire Technology is a micro-cap consumer staples company that designs and distributes branded e-cigarettes and cannabis vaping hardware globally. The company's primary strengths lie in its innovative hardware engineering and dual exposure to both nicotine and legal cannabis markets. Its core investment story centers on scaling high-margin ODM partnerships and capturing demand for smoke-free alternatives. However, the company faces ongoing operational net losses, intense competition from tobacco giants, and strict regulatory headwinds. It represents a higher-risk growth opportunity best suited for speculative investors willing to monitor cash-flow progress and regulatory developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile top-line expansion and entry into cannabis hardware offer growth prospects, profitability is still being established.
Momentum investorStrong fit while signal remains positiveLow float and micro-cap status can occasionally spark sharp price momentum during positive news cycles.
Value investorWeak fitOngoing net losses and negative earnings per share make traditional value metrics inapplicable.
Dividend investorWeak fitThe company pays no dividends, prioritizing growth and cash conservation instead.
Low-risk investorWeak fitHigh share price volatility, micro-cap liquidity, and regulatory exposure create significant risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock exhibits a high beta and sharp price swings common among micro-cap consumer equities.
Valuation riskMedium / highUnpredictable earnings make traditional valuation metrics difficult to rely on.
Competition risk (traditional tobacco and alternative hardware)HighIntense competition from well-funded tobacco giants and low-cost manufacturers threatens market share.
Business qualityMediumInnovative hardware offerings are offset by historical operating losses and negative net margins.
Dividend incomeLow / noneNo dividend is paid, offering zero income return for yield-focused investors.
Execution riskHighManagement must successfully execute cost controls and tariff strategies to achieve cash-flow positivity.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 97.62M USD
Price to earnings Ratio -
1Y Target Price 4.9
Price to earnings Ratio -
1Y Target Price 4.9
Volume (30-day avg) 16.4K shares
Beta 2.02
52 Weeks Range 1.01 - 3.87
Updated Date 11/15/2026
52 Weeks Range 1.01 - 3.87
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.64

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Tobacco

BUY participation
100.0%
Active BUY / eligible
3 / 3
30-Day BUY Count Change
+1

Eligible universe: 3 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -46.05%
Avg. Invested days 19
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ISPR receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by weak unit economics, soft company fundamentals, and weak price momentum.

Company Fundamentals

★★★★★
ISPR has soft overall fundamentals (2 stars), with soft financial health, soft growth momentum, and moderate ownership. In FY2026 versus FY2025, solid earnings growth (+15.4%) is partially offset by weak cash generation (FCF margin -911.7%), negative revenue growth (-24.7%), weak profitability (net margin -34.6%).

Financial Health Rating

★★★★★
ISPR's financial health is soft, with the relatively strongest area being moderate liquidity, including working-capital and asset support (WC/assets 1.2%). Profitability is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is ISPR's strongest growth driver at +15.4% FY2026 versus FY2025 (solid, 4 stars). By comparison, while revenue growth (-24.7%, negative) and free-cash-flow growth (-10229.1%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 7.3% (soft) and 34.8% of outstanding shares are publicly tradable (moderate). Insider ownership of 65.78% supports management-shareholder alignment.

Top 5 Institutional Investors

Yong Rong (HK) Asset Management Ltd 2.60%
Potomac Capital Management, Inc. 1.04%
BlackRock Inc 0.71%
Geode Capital Management, LLC 0.45%
Millennium Management LLC 0.45%

Unit Economics (Per $1K Revenue)

★★★★★
ISPR generates approximately $128 of gross profit, $-339 of operating income, and $-9,117 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and strong capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -3.58% (Tax Credit)

Quantitative Style Profile

★★★★★
ISPR has a Value-Oriented profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
E-Cigarette ProductsSale of branded open- and closed-system nicotine vaping devices globally under the Aspire name.This segment represents core traditional vaping hardware sales distributed internationally.
Cannabis Vaping ProductsOriginal design manufacturing (ODM) and sale of specialized cannabis hardware to operators and brands.Provides exposure to the legal cannabis consumption market through specialized hardware solutions.
Next-Generation Nicotine ProductsAssembly and distribution of modern alternative products such as nicotine pouches.Captures consumer migration toward smoke-free oral nicotine alternatives.

Analyzing Revenue: Products, Geography and Growth

Revenue by Geography

Geography revenue - Year on Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 83.41M
Price to Sales(TTM) 1.02
Enterprise Value 83.41M
Price to Sales(TTM) 1.02
Enterprise Value to Revenue 0.89
Enterprise Value to EBITDA -41.89
Shares Outstanding 57.77M
Shares Floating 20.07M
Shares Outstanding 57.77M
Shares Floating 20.07M
Percent Insiders 65.78
Percent Institutions 7.32

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.